Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alejandro Falcon Gonzalez"'
Autor:
Iwona Lugowska, Carlos Rojas, Alejandro Falcon Gonzalez, Lucia Gonzalez Cortijo, Chih-Hung Hsu, Chia-Jui Yen, Sun Young Rha, Kan Yonemori, Daneng Li, Ravit Geva, Pamela Salman, Eduardo Yanez Ruiz, Qi Liu, Tanya Keenan, Jane Healy, Mariusz Kwiatkowski
Publikováno v:
Cancer Research. 82:CT129-CT129
Background: T-cell immunoreceptor with Ig and ITIM domains (TIGIT) is coexpressed with PD-1 on both CD4+ and CD8+ T cells in tumors. Preclinical models and early clinical data have shown enhanced antitumor activity when an anti-TIGIT antibody is co-a
Autor:
Carmen Kahatt, Luis Paz-Ares, Inmaculada Sanchez-Simon, Elizabeth Jimenez Aguilar, Rafael Nuñez, Santiago Ponce Aix, Sonia Extremera, Alejandro Falcon Gonzalez, Jesus R Fernandez, Elena Brehcist, Julia Martinez, Ali Zeaiter, Gregory M. Cote
Publikováno v:
Journal of Clinical Oncology. 39:5586-5586
5586 Background: LUR is a new agent that exerts antitumor activity through inhibition of trans-activated transcription and modulation of tumor microenvironment. Preclinical synergism/additivity in combination with IRI has been reported, thus promptin
Publikováno v:
Melanoma management. 2(4)
Different treatment modalities encompassed under the term ‘immunotherapy’ have led to major breakthroughs in the treatment of melanoma. Immune checkpoint-blocking antibodies targeting CTLA-4 and PD-1 result in significant activity and prolonged s
Autor:
Alejandro Falcon Gonzalez, Julia Martínez Pérez, Jesus Corral, Miriam Crespo Alonso, Maria Jose Flor Oncala, Inmaculada Sanchez
Publikováno v:
Journal of Thoracic Oncology. 12:S1293-S1294
Autor:
Daniel Herrero, María Rocío Morales Herrero, José Luis López Guerra, Alberto Sánchez Camacho-Mejías, Irene Carrasco García, Paloma Santos Fernández, Carmen Victoria Almeida González, Marta Benavent Viñuales, Alejandro Falcón González, Álvaro Montaño Periáñez, Rosario González Mancha, Francisco Javier Salvador Bofill, Manuel Ruiz Borrego
Publikováno v:
Archives of Breast Cancer (2020)
Background: Male breast cancer (MBC) accounts for less than 1% of breast cancer, requiring extrapolation of results from studies in women. The aim of the study is to evaluate prognostic and therapeutic factors with special focus in endocrine treatmen
Externí odkaz:
https://doaj.org/article/027c49113f9b4b1c8ba36b809b762643